Abiopharma

New Form 8-K - Verve Therapeutics, Inc. Filed: 2025-06-17 AccNo: 0001193125-25-141748 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits